Background: Harm reduction is an essential public health strategy; however, the harm reduction workforce and service landscape remain poorly characterized nationally. HealthHIV launched the State of Harm Reduction™ National Survey in 2023, the first national workforce survey focused exclusively on who delivers harm reduction services, under what conditions, and in what policy contexts.

Methods: The survey included closed- and open-ended questions and was administered to harm reduction service providers across the U.S. and its territories (N=763). We conducted latent class analysis (LCA) to identify workforce profiles; calculated multivariate logistic regressions to examine predictors of naloxone provision and syringe service programs; and conducted a policy environment analysis examining state-level legal status of syringe distribution, naloxone standing orders, mobile outreach, and supervised consumption. Chi-square tests compared service-provision outcomes across legal environments.

Results: LCA identified four distinct workforce profiles: Comprehensive Outreach Harm Reduction (38.0%), Clinical Sexual Health/Prevention (32.6%), Low-Service/Limited-Capacity (17.0%), and Naloxone-Forward Hybrid (12.4%). Classes differed significantly in burnout severity and attrition intent (both p<.001). In regression models, naloxone/Narcan provision was a strong predictor of comprehensive service delivery (aOR=9.85, p<.001). Emotional drain was the dominant predictor of attrition intent (aOR=5.65, p<.001) and was even stronger among the peer workforce (aOR=6.83, p<.001). Leadership disrespect also emerged as a peer-specific predictor of attrition (aOR=3.03, p<.001). Policy environment analyses revealed that organizations in states with legal syringe distribution provided significantly broader arrays of harm reduction services than those operating in legally restrictive environments (p<.05). Workforce burnout was highest in the most legally restrictive contexts.

Conclusions: Findings indicate that significant strain, burnout, legal barriers to services, and funding instability are among the most urgent threats. Policy advocacy to standardize access to naloxone, decriminalize syringe services, and invest in harm reduction workforce development is essential to realizing the public health potential of harm reduction.